StockData
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

Nautilus Biotechnology, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$2.63+0.57 (+27.67%)

Close on Oct 19, 2026

Market cap
$334.37M
P/E (TTM)
–
Dividend yield
–

Nautilus Biotechnology, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Nautilus Biotechnology does not break out revenue by segment, region or product in the tagged data of its filings for this period type.